SequelSEC

MERIT MEDICAL SYSTEMS INC MMSI

Surgical & Medical Instruments & Apparatus · CIK 0000856982 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$1.58B
Fiscal year ended 2026-06-30
Operating income
$201.37M
Fiscal year ended 2026-06-30
Free cash flow
$203.20M
Fiscal year ended 2026-06-30

MERIT MEDICAL SYSTEMS INC (MMSI) reported revenue of $1.58B and net income of $145.56M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from MERIT MEDICAL SYSTEMS INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

MERIT MEDICAL SYSTEMS INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$1.58B
Cost of revenue$797.09M
Gross profit$781.73M
Operating income$201.37M
Net income$145.56M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$194.46M
Income tax expense$48.90M
Diluted EPSUnavailable
Selling, general & administrative$482.07M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

MERIT MEDICAL SYSTEMS INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$448.70M
Total assets$2.86B
Current assets$1.11B
Total liabilities$1.18B
Current liabilities$264.93M
Total equity incl. NCI$1.68B
Temporary (mezzanine) equityUnavailable
Inventory$374.11M
Accounts receivable$224.24M
Goodwill$539.77M
Long-term debt$736.26M
Accounts payableUnavailable

Cash flow

MERIT MEDICAL SYSTEMS INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$283.45M
Capital expenditures$80.24M
Investing cash flow-$176.80M
Financing cash flow-$644.00K
Net change in cash$106.99M
Stock-based compensation$45.38M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$124.35M

Derived

MERIT MEDICAL SYSTEMS INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$203.20M
Gross margin49.5%
Operating margin12.8%
FCF margin12.9%
SBC / revenue2.9%
Current ratio4.20x
Revenue YoY growth10.2%
Net margin9.2%
R&D / revenueUnavailable
CapEx / revenue5.1%
Long-term debt / equity0.44x
Effective tax rate25.1%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MMSI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-24View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-Q · Filed 2025-07-30View SEC filing
10-Q · Filed 2025-04-24View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.